Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LF.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KP.2.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
MD.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
MK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
LZ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
MB.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KP.3.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.1.50NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KP.2.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
unclassifiableNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KS.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HH.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XCENWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HN.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GU.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GQ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.1.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.2.7.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.36NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.44NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2 (Omicron)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.66NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used